The introduction of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable interest within the weight loss community. This novel dual GIP and GLP-1 agonist medication seems to deliver notable improvements in fat reduction compared to previous therapies. Initial research studies have demonstrated substantial decreases in body mass , poss